Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study)Willem Pieter Brouwer, Qing Xie, Ramazan Idılman et al.|Hepatology|2014Cited by 165
Risk Factors of Immune-Mediated Hepatotoxicity Induced by Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review and Meta-AnalysisYing Jiang, Ning‐Ping Zhang, Xiaoyu Li et al.|Current Oncology|2024Cited by 9